Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Should I Hold Hayward Holdings Hayw Stock Now Price At 13.38 Down 0.82 20260402 Is The Beauty Skin Stock Gaining Momentum Price At 0.90 Down 2.48 20260402 Is Eaton Etx Stock Safe To Buy Now Price At 18.41 Down 0.32 20260406 Is Banc Of Cal Banc Stock A Market Leader Price At 17.93 Up 1.70 20260406 What Is The Biggest Uncertainty For Sound Spma Stock Price At 25.14 Up 0.62 20260413 Lifetime Brands LCUT Stock Growth Potential Institutional Selling 20260418 What Basel Medical BMGL is doing that separates it from the herd 013 20260508 Heartbeam BEAT Stock Risk Factors Skyrockets 20260418 ATR AptarGroup Inc posts modest Q4 2025 EPS beat and 54 percent YoY revenue growth shares dip 105 percent today Is Doximity DOCS stock stable under market conditions Doximity posts 12 EPS beat solid Q1 revenue MITTB TPG reaffirms commitment to stable preferred dividends in its latest quarterly update How GAMCO GNT stacks up against analyst expectations Technical Strength 20260511 Is Revolution Medicines RVMD stock weakening in trend Hovering 20260420 Why WaterBridge WBI might surprise investors this quarter Technical Strength 20260511 AGEN beats Q4 estimates with 71 EPS surprise yet Agenus shares slip 36 on uncertainty What Greenidge GREE capital allocation tells us Greenidge 44 Pct EPS Surprise On Narrower Loss What Bioceres BIOX is building for the next decade Momentum Fading 20260508 FHNH First reports no available quarterly earnings or revenue data for its Series H preferred shares Impact BioMedical IBO CEO lays out novel drug pipeline priorities to drive longterm global market expansion Franklin Wireless Navigates Revenue Decline Amid Strategic Shift from Hotspot Devices Kevin Warshs Preferred Inflation Measure Faces Scrutiny as Bank of America Warns of Potential Pitfalls Cisco Reports Third Quarter Earnings Key Takeaways from the Latest Results Trainline Revises Guidance Upward for Second Time in 2026 Should You Sell CorVel CRVL After 065 Drop 20260517 Celcuity CELC Trading at 13176 Key Decision Point 20260519 April Jobs Report Shows Cooling Yet Resilient Labor Market Aluminum Surge Strains Major US Companies as Iran Conflict Disrupts Supply Chains LG Display LPL Q4 2025 Earnings Massive EPS Miss Amid Unexplained Stock Rally Nvidia Reassures Skeptics AI is Poised for Mainstream Adoption Dividend and Buybacks Signal Confidence Retail Investors Gain Direct Access to SpaceX IPO via Major Brokerage Platforms Redington Solar Partners with FIMER to Distribute String Inverter Portfolio for Indian Solar Market Fed Chair Powell Vows Not to Be a Shadow Chair as Potential Clash with Warsh Looms Trumps 50 Million Magnificent Seven Stock Trades in Q1 2026 Apple and Alphabet Buys Tesla Sales Gen Z Thirst for Bargains Boosts Discount Retailers Walmart and Ross Wholesale Inflation Surges 6 Annually in April Marking Largest Jump Since 2022 European Companies Pursue Reindustrialisation Amid Declining Investment Plans and AIs Growing Economic Role BIPC Q1 2026 Earnings Wide Earnings Miss on Significant EPS Shortfall GBCI Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22 BGS Q1 2026 Earnings Earnings Beat Estimates by 457 as Bottom Line Exceeds Expectations Hut 8 Corp Q3 2024 Earnings Narrows Loss Expectancy with EPS Beat Defi Technologies DEFT Tests Support at 066 After 21 Decline Key Levels in Focus Chemours CC Holds Steady Near Support as Consolidation Continues Arena Group Holdings AREN Shares Edge Higher as Support Level Holds Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten Lockheed Martin Graham Stephans Bullish Outlook on Defense Giant Gains Relevance Amid Geopolitical Tensions Trump Concludes China Visit Amid Trade Oil and Taiwan Talks SCCO Q1 2026 Earnings Strong Earnings Beat Drives Share Gains IDXX Q1 2026 Earnings Modest EPS Beat Amid Flat Revenue Backdrop Adagene Q2 2025 Earnings Clinical Progress Overshadows EPS Miss Shares Jump